Abstract

Keywords
Get full access to this article
View all access options for this article.
References
1.
Corrin
B
Liebow
AA
Friedman
PJ
. Pulmonary lymphangiomyomatosis. A review . Am J Pathol
1975 ; 79 (2 ): 348 –82 .
2.
LAM Foundation
(website: www.thelamfoundation.org).
3.
Davies
DM
Johnson
SR
Tattersfield
AE
Kingswood
JC
Cox
JA
McCartney
DL
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis . NEMJ
2008 ; 358 : 200 –02 .
4.
Bernstein
SM
Newell
JD
Jr
Adamczyk
D
Mortenson
RL
King
TE
Jr
Lynch
DA
How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis?
Am J Resp Crit Care Med
1995 ; 152 (6 ): 2138 –43 .
5.
Abbot
GF
de Christenson
ML Ronaldo
Frazier
AA
Pugatch
RD
Galvin
JR
. Lymphangioleioyomatosis: radiologic—pathologic correlation . Radiographics
2005 ; 25 : 803 –28 .
6.
Gotway
MB
Reddy
GP
Webb
WR
Elicker
B
Leung
JWT
. High-resolution CT of the lung: patterns of disease and diffeewntial diagnosis . Radiol Clin N Am
2005 ; 43 : 513 –42 .
7.
Guinee
DG
Jr
Feuerstein
I
Koss
MN
Travis
WD
. Pulmonary lymphangioleiomyomatosis: Diagnosis based on results of transbronchial biopsy and immunohistochemical studies and correlation with high resolution computed tomography findings. Arch on results of transbronchial biopsy and immunohistochemical studies and correlation with highresolution computed tomography findings . Arch Path Lab Med
1994 ; 118 : 846 –9 .
8.
Young
LR
Inoue
Y
McCormack
FX
. Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis . NEJM
2008 ; 358 : 199 –200 .
9.
Lazor
R
Valeyre
D
Lacronique
J
Wallaert
B
Urbane
T
Cordier
JF
. The Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires. Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis . Respir Med
2004 ; 98 (6 ): 536 –41 .
